S100A9 and acute lymphoblastic leukemia: When comparing the ALL and sJIA groups, the area under the curve (AUC) of IL-18, S100A8, and S100A9 was greater than 90%, which suggested a remarkable sensitivity and specificity of these three biomarkers in differentiating sJIA from ALL.